MGC's Cannabinoid Drugs For Epilepsy, Dementia and Alzheimer's To Reach Several European Countries
MGC Pharmaceuticals Ltd. (OTCPK:MGCLF) (LSE:MXC) (ASX:MXC) has signed an exclusive distribution agreement with Sciensus Rare, for the distribution of CannEpil and CogniCann.